Comparative in-vitro activity of fourteen antibiotics against clinical isolates of enterococci

Journal of Chemotherapy
A T Abd-Elalim Eltahawy, R M Fouad Khalaf

Abstract

The in-vitro antibacterial activities of fourteen antimicrobial agents, including ampicillin, amikacin, Augmentin, ceftazidime, cefotaxime, ceftriaxone, ciprofloxacin, erythromycin, gentamicin, penicillin G, piperacillin, rifampicin, streptomycin and vancomycin, were compared against 195 enterococcal strains isolated from clinical specimens received at the King Abdulaziz University Hospital in Saudi Arabia. The antibacterial susceptibility was determined by the minimal inhibitory concentration (MIC) using an agar dilution method. Ampicillin, Augmentin and vancomycin exhibited the greatest activity, inhibiting 90% of the tested strains (MIC90) at 2 micrograms/ml, followed by penicillin G and piperacillin with MIC90 of 4 micrograms/ml. Erythromycin, third generation cephalosporins, aminoglycosides and rifampicin, on the other hand, had poor activity against enterococci with MIC90s well above the obtainable serum concentrations. The clinical implications of resistance to aminoglycosides and the alternative antimicrobial therapy in serious enterococcal infections are discussed in the text.

References

Aug 1, 1979·The Journal of Infectious Diseases·R C MoelleringC B Wennersten
Jul 21, 1988·The New England Journal of Medicine·R LeclercqP Courvalin
Dec 1, 1986·Antimicrobial Agents and Chemotherapy·B E MurrayB Mederski-Samoraj
May 1, 1987·Annals of Internal Medicine·M J ZervosD R Schaberg
Jan 1, 1988·Antimicrobial Agents and Chemotherapy·J E PattersonM J Zervos
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·J F Acar, A Y Buu-Hoi
Jan 1, 1985·Scandinavian Journal of Infectious Diseases·A Forsgren
May 1, 1985·The Journal of Antimicrobial Chemotherapy·A KingI Phillips
Jun 1, 1988·Journal of Clinical Microbiology·A H KaplanR R Facklam
Jul 1, 1985·Reviews of Infectious Diseases·H KroppF M Kahan
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·G M EliopoulosR C Moellering
Dec 1, 1971·The Journal of Infectious Diseases·R C MoelleringA N Weinberg
May 1, 1970·The American Journal of the Medical Sciences·G L MandellE W Hook
Aug 1, 1983·American Journal of Infection Control·M WhitesideK Ratzan
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·R W TofteK B Crossley

❮ Previous
Next ❯

Citations

Jul 5, 2012·Journal of Chemotherapy·Saber YezliZiad A Memish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.